4//SEC Filing
Lee Tien-Li 4
Accession 0000950170-25-023253
CIK 0001774857other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:35 PM ET
Size
9.0 KB
Accession
0000950170-25-023253
Insider Transaction Report
Form 4
Lee Tien-Li
DirectorChief Executive Officer10% Owner
Transactions
- Conversion
Common Stock
2025-02-14+41,303→ 1,479,633 total - Purchase
Common Stock
2025-02-14$16.00/sh+16,542$264,672→ 1,496,175 total - Conversion
Series A Convertible Preferred Stock
2025-02-14−350,002→ 0 total→ Common Stock (41,303 underlying)
Holdings
- 1,474,028(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The Series A Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the "Issuer") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series A Convertible Preferred Stock had no expiration date.
Documents
Issuer
Aardvark Therapeutics, Inc.
CIK 0001774857
Entity typeother
Related Parties
1- filerCIK 0001940120
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:35 PM ET
- Size
- 9.0 KB